Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray
AptarGroup, Inc. (ATR)
Last aptargroup, inc. earnings: 4/30 05:04 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.aptar.com
Company Research
Source: Business Wire
Supporting advancement of complex intranasal therapies through clinical development CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its proprietary nasal delivery system is being utilized in LTR Pharma Limited’s (ASX:LTP) Phase II clinical study of SPONTAN®, an investigational intranasal spray under development for the treatment of erectile dysfunction. This milestone reflects Aptar Pharma’s continued commitment to supporting intranasal drug delivery technologies and supporting the development of innovative, patient-centric therapies.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316608983/en/Aptar’s Intranasal Delivery System Utilized in Phase II Clinical Study of SPONTAN® Nasal SprayLTR Pharma recently announced the dosing of the first patients in the Phase II study of SPONTAN
Show less
Read more
Impact Snapshot
Event Time:
ATR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATR alerts
High impacting AptarGroup, Inc. news events
Weekly update
A roundup of the hottest topics
ATR
News
- Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray [Yahoo! Finance]Yahoo! Finance
- New Strong Sell Stocks for March 9th [Yahoo! Finance Canada]Yahoo! Finance Canada
- Pharmaceutical Packaging Market Trends and Growth Projections to 2030 Featuring Profiles of AptarGroup, Amcor, SGD Pharma, West Pharmaceutical Services, SCHOTT Pharma and Other Key Players [Yahoo! Finance]Yahoo! Finance
- Aptar to Participate in Upcoming Investor ConferencesBusiness Wire
- AptarGroup, Inc.'s (NYSE:ATR) Intrinsic Value Is Potentially 58% Above Its Share Price [Yahoo! Finance]Yahoo! Finance
ATR
Earnings
- 2/5/26 - Miss
ATR
Sec Filings
- 3/3/26 - Form 4
- 2/27/26 - Form 4
- 2/27/26 - Form 4
- ATR's page on the SEC website